1-(5-甲氧基-2-吡啶)乙酮 | 325796-84-7

• 分子结构分类: 有机化合物 - 有机氧化合物
• 中文名称: 1-(5-甲氧基-2-吡啶)乙酮
• 英文名称: 1-(5-Methoxypyridin-2-yl)-ethanon
• 英文别名: 1-(5-methoxypyridin-2-yl)ethanone；1-(5-methoxypyridin-2-yl)ethan-1-one；2-Acetyl-5-methoxypyridin；1-(5-methoxypyridin-2-yl)-1-ethanone
• CAS: 325796-84-7
• 化学式: C₈H₉NO₂
• 分子量: 151.165
• InChiKey: JCFAFZULKPYMQV-UHFFFAOYSA-N

物化性质

• 沸点：
  268.1±20.0 °C(Predicted)
• 密度：
  1.093±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  0.8
• 重原子数：
  11
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.25
• 拓扑面积：
  39.2
• 氢给体数：
  0
• 氢受体数：
  3

安全信息

• 海关编码：
  2933399090

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Product Name: 1-(5-Methoxypyridin-2-yl)ethanone
Synonyms:

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

---

Section 3. Composition/information on ingredients.
Ingredient name: 1-(5-Methoxypyridin-2-yl)ethanone
CAS number: 325796-84-7

---

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels.
Storage:

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C8H9NO2
Molecular weight: 151.2

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  1-(5-甲氧基-2-吡啶)乙酮 在 氢溴酸 、 溶剂黄146 、 pyridinium hydrobromide perbromide 作用下， 以 乙醇 为溶剂， 反应 6.0h， 生成 N-(4-isopropoxypyridin-2-yl)-4-(5-methoxypyridin-2-yl)thiazol-2-amine
  参考文献：
  名称：

  [EN] HETEROCYCLIC COMPOUNDS AND THEIR USE FOR TREATMENT OF HELMINTHIC INFECTIONS AND DISEASES
  [FR] COMPOSÉS HÉTÉROCYCLIQUES ET LEUR UTILISATION POUR LE TRAITEMENT DE MALADIES ET INFECTIONS HELMINTHIQUES

  摘要：

  本文提供了公式(I)、公式(II)、公式(III)、公式(IIIa)、公式(Mb)、公式(IIIc)、公式(Hid)、公式(IV)、公式(IVa)、公式(IVb)和公式(IVc)的杂环化合物，以及其药学上可接受的盐、互变异构体、同位素拓扑异构体和立体异构体，包含有效量的公式(I)、公式(II)、公式(III)、公式(IIIa)、公式(Mb)、公式(IIIc)、公式(Hid)、公式(IV)、公式(IVa)、公式(IVb)和公式(IVc)的杂环化合物的组合物，以及用于治疗或预防动物和人类丝虫感染和疾病的方法。

  公开号：

  WO2022087326A1
• 作为产物：
  描述：

  2-溴-3-甲氧基-6-硝基吡啶 在 palladium on activated charcoal 正丁基锂 、 溴 、 一水合肼 作用下， 以 四氢呋喃 、 乙醇 、 正己烷 、 氢溴酸 为溶剂， 反应 4.0h， 生成 1-(5-甲氧基-2-吡啶)乙酮
  参考文献：
  名称：

  Reimann; Erdle, Pharmazie, 2000, vol. 55, # 12, p. 907 - 912

  摘要：

  DOI：

文献信息

• [EN] AMINOQUINAZOLINE COMPOUNDS AS A2A ANTAGONIST<br/>[FR] COMPOSÉS D'AMINOQUINAZOLINE COMME ANTAGONISTES D'A2A
  申请人：MERCK SHARP & DOHME

  公开号：WO2016126570A1

  公开（公告）日：2016-08-11

  The present invention is directed to compounds of generic formula I: or pharmaceutically acceptable salts thereof that are believed to be useful as an A2A-receptor antagonist.

  本发明涉及通用式I的化合物或其药用可接受的盐，据信可用作A2A受体拮抗剂。
• Thieno-pyrimidine compounds having fungicidal activity
  申请人：Brewster Kirkland William

  公开号：US20060089370A1

  公开（公告）日：2006-04-27

  The present invention relates to thieno[2,3-d]-pyrimidine compounds having fungicidal activity.

  本发明涉及具有杀真菌活性的噻吩[2,3-d]-嘧啶化合物。
• An Investigation of Structure-Activity Relationships of Azolylacryloyl Derivatives Yielded Potent and Long-Acting Hemoglobin Modulators for Reversing Erythrocyte Sickling
  作者：Abdelsattar M. Omar、Osheiza Abdulmalik、Mohini S. Ghatge、Yosra A. Muhammad、Steven D. Paredes、Moustafa E. El-Araby、Martin K. Safo

  DOI：10.3390/biom10111508

  日期：——

  Aromatic aldehydes that bind to sickle hemoglobin (HbS) to increase the protein oxygen affinity and/or directly inhibit HbS polymer formation to prevent the pathological hypoxia-induced HbS polymerization and the subsequent erythrocyte sickling have for several years been studied for the treatment of sickle cell disease (SCD). With the exception of Voxelotor, which was recently approved by the U.S

  芳香醛与镰状血红蛋白 (HbS) 结合，增加蛋白氧亲和力和/或直接抑制 HbS 聚合物形成，以防止病理性缺氧诱导的 HbS 聚合和随后的红细胞镰状化，多年来一直在研究用于治疗镰状细胞疾病（SCD）。除了最近被美国食品和药物管理局（FDA）批准用于治疗该疾病的 Voxelotor 之外，其他几种有前景的抗镰状芳香醛在临床上表现不佳，因为醛部分的代谢不稳定，这是至关重要的来了解这些化合物的药理活性。多年来，我们的团队合理地开发了芳香醛的类似物，其中包含稳定的迈克尔加成反应中心，我们假设该中心会与 Hb 形成共价相互作用，以增加蛋白质对氧的亲和力并防止红细胞镰状化。尽管这些化合物已被证明是代谢稳定的，但不幸的是它们表现出弱甚至没有抗镰化活性。在这项研究中，通过对我们的先导迈克尔加成化合物进行额外的针对性修饰，我们发现了其他新型抗镰刀化剂。这些化合物被命名为 MMA，与 α-珠蛋白和/或 β-珠蛋白结合，增加
• AMIDE COMPOUNDS AND METHOD FOR MAKING AND USING
  申请人：Tso Kin

  公开号：US20180111917A1

  公开（公告）日：2018-04-26

  Disclosed embodiments concern novel interleukin receptor associated kinases (IRAK) inhibitors and compositions comprising such inhibitors. Also disclosed are methods of making and using the compounds and compositions. The disclosed compounds and/or compositions may be used to treat or prevent an IRAK-associated disease or condition.

  揭示的实施例涉及新型白细胞介素受体相关激酶（IRAK）抑制剂和包含此类抑制剂的组合物。还揭示了制备和使用这些化合物和组合物的方法。所揭示的化合物和/或组合物可用于治疗或预防与IRAK相关的疾病或症状。
• Palladium-Catalyzed Divergent Arylation with Triazolopyridines: One-Pot Synthesis of 6-Aryl-2-α-styrylpyridines
  作者：Youngtaek Moon、Soonhyung Kwon、Dahye Kang、Honggu Im、Sungwoo Hong

  DOI：10.1002/adsc.201500967

  日期：2016.3.17

  We have developed a new strategy for palladium‐catalyzed arylation reactions with triazolopyridines, wherein two different chemical transformations (C‐3 vs. C‐7) are observed by differentiating the substrates using different bases. The reactive palladium carbenoids were directly generated from triazolopyridines and underwent denitrogenative arylations with aryl bromides. Intriguingly, when potassium

  我们已经开发了一种新的策略用于三唑并吡啶进行的钯催化的芳基化反应，其中通过使用不同的碱区分底物，观察到两种不同的化学转化（C-3与C-7）。反应性钯类胡萝卜素直接由三唑并吡啶产生，并用芳基溴化物进行脱氮芳基化。有趣的是，当碳酸钾用氢替换叔丁醇，直接Ç  ħ芳基化发生在酸性最强的位置（C-7）。此外，以一锅法成功地进行了两次不同的催化芳基化反应，为获得6-芳基-2-α-苯乙烯基吡啶提供了便利。